Recovery | Combined Endpoint | p-value | OR (CI 95%) | |
---|---|---|---|---|
(n = 34) | (n = 11) | |||
Age (years) | 32.8 ± 14.7 | 48.4 ± 13.2 | 0.05 | |
male | 24 (71) | 5 (45) | 0.16 | 2.9 (0.86–1.25) |
Clinical Presentation | ||||
Chest Pain | 21 (62) | 5 (45) | 0.49 | 0.5 (0.13–1.83) |
Palpitations | 3 (9) | 4 (36) | 0.05 | 5.9 (1.27–26.33) |
Fatigue | 25 (74) | 8 (73) | 0.99 | 0.9(0.24–3.39) |
Dyspnoea (NYHA Class) | ||||
III | 8 (24) | 6 (55) | 0.07 | 3.9 (1.04–16.96) |
IV | 4 (12) | 2 (18) | 0.62 | 1.7 (0.28–8.62) |
Blood Testing | ||||
Troponin (ng/ml) | 363 ± 8135 | 103 ± 143 | 0.19 | |
BNP (pg/ml) | 4046 ± 8135 | 3636 ± 2497 | 0.91 | |
EMB Results | ||||
Imflammation on EMB | 15 (54) | 5 (50) | 0.99 | 1.0 (0.29–4.21) |
Presence of virus genome | 13 (52) | 8 (73) | 0.29 | 2.5 (0.57–9.91) |
CMR Parameters | ||||
LVEF (%) | 44 ± 13 | 33 ± 14 | 0.02 | |
LVEF <30% | 7 (21) | 7 (64) | 0.02 | 6.8 (1.56–24.12) |
Presence of LGE | 26 (76) | 10 (91) | 0.25 | 4.2 (0.62–49.34) |
T2 Ratio >1.9 | 14 (41) | 5 (45) | 0.99 | 1.2 (0.31–4.09) |
Global T2 Time (ms) | 66.8 ± 4.9 | 71.8 ± 5.7 | 0.01 | |
Global T2 Time, >2SD | 12 (35) | 8 (73) | 0.04 | 4.9 (1.1–18.9) |
Global T2 Time, >4SD | 4 (12) | 5 (45) | 0.02 | 6.3 (1.2–24.9) |
Fraction with T2 Time >80 ms (%) | 15.1 ± 8.7 | 27.5 ± 14.9 | 0.03 | |
Fraction with T2 Time >80 ms, >2SD | 23 (68) | 10 (91) | 0.24 | 4.7 (0.7–56.2) |
Fraction with T2 Time >80 ms, >4SD | 12 (35) | 8 (73) | 0.04 | 4.9 (1.1–18.9) |